Evidence map›Paper›PMID 38388374›Full record

SynthesisReproductive health2024

Ranking the dietary interventions by their effectiveness in the management of polycystic ovary syndrome: a systematic review and network meta-analysis.

Anna Evelin Juhász, Márton Péter Stubnya, Brigitta Teutsch, Noémi Gede, Péter Hegyi, Péter Nyirády, Ferenc Bánhidy, Nándor Ács, Réka Juhász

Open access · goldAbstract readSystematic ReviewNetwork Meta-Analysis
In one paragraph

Synthesis in Reproductive health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 4 pooled it
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 4 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Anna Evelin JuhászCenter for Translational Medicine, Semmelweis University, Budapest, Hungary.
Márton Péter StubnyaCenter for Translational Medicine, Semmelweis University, Budapest, Hungary.
Brigitta TeutschCenter for Translational Medicine, Semmelweis University, Budapest, Hungary.
Noémi GedeInstitute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
Péter HegyiCenter for Translational Medicine, Semmelweis University, Budapest, Hungary.
Péter NyirádyCenter for Translational Medicine, Semmelweis University, Budapest, Hungary.
Ferenc BánhidyCenter for Translational Medicine, Semmelweis University, Budapest, Hungary.
Nándor ÁcsCenter for Translational Medicine, Semmelweis University, Budapest, Hungary.
Réka JuhászCenter for Translational Medicine, Semmelweis University, Budapest, Hungary. hermanne.juhasz.reka@semmelweis.hu.
Semmelweis University · HUUniversity of Pecs · HU

Funding

New National Excellence Program of the Ministry for Innovation and Technology BT - ÚNKP-22-3-I-PTE-1693
6 · The paper itself

Abstract

introductionPolycystic ovary syndrome (PCOS) is a common condition in women, characterised by reproductive and metabolic dysfunction. While dietary approaches have been evaluated as a first-line treatment for patients with PCOS, there is limited evidence to support preference for a specific dietary composition. This systematic review and network meta-analysis was performed with the objective of comparing different dietary interventions in terms of positive impact. Metformin, the currently preferred treatment, was also compared.

methodsThe latest systematic search was performed on the 20th of March, 2023. Eligible randomised controlled trials (RCTs) included patients with PCOS and compared the dietary approach with another intervention or a standard diet. Outcomes were expressed via anthropometric measurements and hormonal, glycemic, and lipid levels. The Bayesian method was used to perform a network meta-analysis and to calculate the surface under the cumulative ranking curve (SUCRA) values in order to rank the dietary interventions. The overall quality of the evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation system.

results19 RCTs were identified, comprising data from 727 patients who were variously treated with 10 types of dietary interventions and metformin. The Dietary Approaches to Stop Hypertension (DASH) diet was the most effective in reducing Homeostatic Model Assessment of Insulin Resistance (SUCRA 92.33%), fasting blood glucose (SUCRA 85.92%), fasting insulin level (SUCRA 79.73%) and triglyceride level (SUCRA 82.07%). For body mass index (BMI), the most effective intervention was the low-calorie diet (SUCRA 84.59%). For weight loss, the low-calorie diet with metformin (SUCRA 74.38%) was the most effective intervention. Metformin produced the greatest reductions in low-density lipoprotein cholesterol (SUCRA 78.08%) and total testosterone levels (SUCRA 71.28%). The low-carb diet was the most effective intervention for reducing cholesterol levels (SUCRA 69.68%), while the normal diet (SUCRA 65.69%) ranked first for increasing high-density lipoprotein cholesterol levels.

conclusionDietary interventions vary in their effects on metabolic parameters in women with PCOS. Based on our results, the DASH diet is the most effective dietary intervention for treating PCOS. Registration PROSPERO ID CRD42021282984.

Indexed as

Polycystic Ovary SyndromeFemaleHumansHypoglycemic AgentsMetforminRandomized Controlled Trials as TopicHypoglycemic AgentsMetforminAnd weight lossDietInsulin resistanceObesity

Identifiers

PMID38388374
PMCPMC10885527
OpenAlexW4392044267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.